[go: up one dir, main page]

MA28949B1 - Alcools gras de longueur de chaine moyenne en tant que stimulateurs de l'hematopoiese - Google Patents

Alcools gras de longueur de chaine moyenne en tant que stimulateurs de l'hematopoiese

Info

Publication number
MA28949B1
MA28949B1 MA29857A MA29857A MA28949B1 MA 28949 B1 MA28949 B1 MA 28949B1 MA 29857 A MA29857 A MA 29857A MA 29857 A MA29857 A MA 29857A MA 28949 B1 MA28949 B1 MA 28949B1
Authority
MA
Morocco
Prior art keywords
hematopoiese
stimulators
chain length
fatty alcohols
medium chain
Prior art date
Application number
MA29857A
Other languages
English (en)
Inventor
Christopher Penney
Lyne Gagnon
Jean Barabe
Original Assignee
Prometic Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Biosciences Inc filed Critical Prometic Biosciences Inc
Publication of MA28949B1 publication Critical patent/MA28949B1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA29857A 2004-10-01 2007-04-27 Alcools gras de longueur de chaine moyenne en tant que stimulateurs de l'hematopoiese MA28949B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61447804P 2004-10-01 2004-10-01

Publications (1)

Publication Number Publication Date
MA28949B1 true MA28949B1 (fr) 2007-10-01

Family

ID=36916133

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29857A MA28949B1 (fr) 2004-10-01 2007-04-27 Alcools gras de longueur de chaine moyenne en tant que stimulateurs de l'hematopoiese

Country Status (22)

Country Link
EP (1) EP1804780B1 (fr)
JP (1) JP4948414B2 (fr)
KR (1) KR101441022B1 (fr)
CN (1) CN101031288B (fr)
AP (1) AP2007003968A0 (fr)
AT (1) ATE533479T1 (fr)
AU (1) AU2005327498B2 (fr)
BR (1) BRPI0516827A (fr)
CA (1) CA2582262C (fr)
DK (1) DK1804780T3 (fr)
EA (1) EA200700741A1 (fr)
ES (1) ES2376201T3 (fr)
IL (1) IL182209A (fr)
MA (1) MA28949B1 (fr)
MX (1) MX2007003967A (fr)
NO (1) NO338411B1 (fr)
NZ (1) NZ554176A (fr)
PT (1) PT1804780E (fr)
SG (1) SG156611A1 (fr)
TN (1) TNSN07112A1 (fr)
WO (1) WO2006086871A1 (fr)
ZA (1) ZA200702532B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201414122D0 (en) * 2014-08-08 2014-09-24 Cyprus Foundation For Muscular Dystrophy Res The Methods
JP7348064B2 (ja) 2017-01-09 2023-09-20 アポセンス リミテッド 分子を経膜送達するための化合物及び方法
WO2019130319A1 (fr) 2018-01-01 2019-07-04 Aposense Ltd. Composés et procédés pour l'administration transmembranaire de molécules
SG11202103011YA (en) 2018-10-11 2021-04-29 Basf As Aromatic compounds and pharmaceutical uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1605128A (en) * 1977-05-31 1981-12-16 Stafford Miller Ltd Use of higher alcohols as toxicants against mites
JPS6112622A (ja) 1984-06-29 1986-01-21 Kuraray Co Ltd 造血幹細胞の分化増殖促進剤
US5496836A (en) * 1994-05-05 1996-03-05 Mount Sinai School Of Medicine Of The City University Of New York Use of famotidine and related compounds in the treatment of movement disorders
AU7082694A (en) 1994-05-10 1995-11-29 Kitasato Institute, The Hematopoietic stem cell proliferation accelerator
US20030072720A1 (en) * 1998-04-06 2003-04-17 Innoscent Ltd. Oral antimicrobial and anti-odor compositions
US20020076443A1 (en) * 2000-06-19 2002-06-20 Stanley Stein Multiple phase cross-linked compositions and uses thereof
OA12506A (en) 2001-04-18 2006-05-29 Prometic Biosciences Inc Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors.
ATE550018T1 (de) * 2002-09-26 2012-04-15 Mandom Corp Antiseptische bakterizide und die antiseptischen bakterizide enthaltende kosmetika, arzneistoffe und lebensmittel
WO2004069237A1 (fr) 2003-02-07 2004-08-19 Prometic Biosciences Inc. Acides gras a chaine moyenne, glycerides et analogues utilises en tant que stimulateurs de l'erythropoiese

Also Published As

Publication number Publication date
CN101031288B (zh) 2010-11-03
EA200700741A1 (ru) 2007-08-31
KR101441022B1 (ko) 2014-09-18
JP2008514652A (ja) 2008-05-08
TNSN07112A1 (en) 2008-06-02
CA2582262C (fr) 2013-01-08
HK1111358A1 (en) 2008-08-08
IL182209A0 (en) 2008-04-13
AU2005327498A1 (en) 2006-08-24
NO338411B1 (no) 2016-08-15
JP4948414B2 (ja) 2012-06-06
KR20070083630A (ko) 2007-08-24
AP2007003968A0 (en) 2007-04-30
WO2006086871A1 (fr) 2006-08-24
DK1804780T3 (da) 2012-02-06
EP1804780A1 (fr) 2007-07-11
SG156611A1 (en) 2009-11-26
ES2376201T3 (es) 2012-03-09
BRPI0516827A (pt) 2008-09-23
ATE533479T1 (de) 2011-12-15
AU2005327498B2 (en) 2012-01-19
CA2582262A1 (fr) 2006-08-24
ZA200702532B (en) 2008-11-26
EP1804780A4 (fr) 2009-08-12
NO20071659L (no) 2007-06-21
MX2007003967A (es) 2008-03-04
EP1804780B1 (fr) 2011-11-16
IL182209A (en) 2011-02-28
PT1804780E (pt) 2012-01-19
NZ554176A (en) 2010-04-30
CN101031288A (zh) 2007-09-05

Similar Documents

Publication Publication Date Title
EP2187742A4 (fr) Dérivés de benzylbenzène et procédés d'utilisation
BRPI0815079A2 (pt) Composto dericado de 1,2-diamido-etileno, composição farmacêutica que contém e uso desse composto
CR10743A (es) Derivados de azaadamantano y metodos de uso de los mismos
BRPI0719849A2 (pt) Método de imunização contra os quatro sorotipos da dengue
EP2059123A4 (fr) Formulations d'émulsions de pickering
EP2068624A4 (fr) Formulations d'émulsions de pickering
CY2014026I2 (el) Συνθεσεις και χρησεις για θεραπεια σκληρυνσης κατα πλακας
FI20000416L (fi) Ihmiselimistöön liittyvä mittaus
BRPI0909954A2 (pt) "diazacarbazóis e métodos de uso"
BRPI0719497A2 (pt) "composição, processo de preparação de uma composição, usos de uma composição e uso coméstico de uma composição"
FI20021947A7 (fi) Menetelmä triglyseridien rasvahappoketjukoostumuksen säätämiseksi sekä menetelmän käyttö
BRPI0813341A2 (pt) " uso de compostos, composições curáveis, e, uso de composições curáveis ".
FI20031190L (fi) Antioksidantti ja sen käyttö
MA28900B1 (fr) Composes et compositions en tant que modulateurs ppar
NO20043937L (no) Anvendelse av vitamin D sammensetninger
IL205350A0 (en) Novel 1, 3- dihydro - 5 - isobenzofurancarbonitrile derivatives and pharmacetical composition thereof for the treatment of premature ejaculation
MA28949B1 (fr) Alcools gras de longueur de chaine moyenne en tant que stimulateurs de l'hematopoiese
DE602004008944D1 (de) Herstellung einer alkoxylatzusammensetzung
DE50303289D1 (de) Ölkörper für kosmetische zusammensetzungen enthaltend cyclohexylcyclohexan
FR2920774B1 (fr) Nouveaux derives de n-phenul acatamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contentant
DE602004018858D1 (de) Emulsionszusammensetzung
DE50305218D1 (de) Transformator
FR2865938B1 (fr) Formulation retard solide comprenant de l'acetate de triptoreline
DE502004003507D1 (de) Hydrodynamische kupplung
WO2010000573A3 (fr) Agents de conditionnement capillaire contenant des imidazolines